295 related articles for article (PubMed ID: 27168191)
1. Levetiracetam for seizure prevention in brain tumor patients: a systematic review.
Nasr ZG; Paravattil B; Wilby KJ
J Neurooncol; 2016 Aug; 129(1):1-13. PubMed ID: 27168191
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
Yang Y; Zheng F; Xu X; Wang X
CNS Drugs; 2016 Aug; 30(8):677-88. PubMed ID: 27395404
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review.
Lee YJ; Kim T; Bae SH; Kim YH; Han JH; Yun CH; Kim CY
CNS Drugs; 2013 Sep; 27(9):753-9. PubMed ID: 23921717
[TBL] [Abstract][Full Text] [Related]
4. Antiepileptic drugs for treating seizures in adults with brain tumours.
Kerrigan S; Grant R
Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD008586. PubMed ID: 21833969
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis.
Pourzitaki C; Tsaousi G; Apostolidou E; Karakoulas K; Kouvelas D; Amaniti E
Br J Clin Pharmacol; 2016 Jul; 82(1):315-25. PubMed ID: 26945547
[TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of levetiracetam versus phenytoin for seizure prophylaxis after traumatic brain injury: A systematic review and meta-analysis.
Xu JC; Shen J; Shao WZ; Tang LJ; Sun YZ; Zhai XF; Qi L; Li J; Zheng JY
Brain Inj; 2016; 30(9):1054-61. PubMed ID: 27295203
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam versus phenytoin for seizure prophylaxis in brain injured patients: a systematic review and meta-analysis.
Chaari A; Mohamed AS; Abdelhakim K; Kauts V; Casey WF
Int J Clin Pharm; 2017 Oct; 39(5):998-1003. PubMed ID: 28780739
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors.
Newton HB; Dalton J; Goldlust S; Pearl D
J Neurooncol; 2007 Sep; 84(3):293-6. PubMed ID: 17431542
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam for seizures in children with brain tumors and other cancers.
Partap S; Fisher PG
Pediatr Blood Cancer; 2009 Feb; 52(2):288-9. PubMed ID: 18831033
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam Prophylaxis for Post-traumatic Brain Injury Seizures is Ineffective: A Propensity Score Analysis.
Zangbar B; Khalil M; Gruessner A; Joseph B; Friese R; Kulvatunyou N; Wynne J; Latifi R; Rhee P; O'Keeffe T
World J Surg; 2016 Nov; 40(11):2667-2672. PubMed ID: 27307089
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study.
Iuchi T; Kuwabara K; Matsumoto M; Kawasaki K; Hasegawa Y; Sakaida T
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1158-62. PubMed ID: 25511789
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage.
Bansal S; Blalock D; Kebede T; Dean NP; Carpenter JL
J Neurosurg Pediatr; 2014 Feb; 13(2):209-15. PubMed ID: 24286154
[TBL] [Abstract][Full Text] [Related]
13. Seizure risk in brain tumor patients with conversion to generic levetiracetam.
Armstrong TS; Choi S; Walker J; Gilbert MR
J Neurooncol; 2010 May; 98(1):137-41. PubMed ID: 19936624
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of levetiracetam versus phenytoin in the prevention of late post-traumatic seizures and survey of UK neurosurgical prescribing practice of antiepileptic medication in acute traumatic brain injury.
Bakr A; Belli A
Br J Neurosurg; 2018 Jun; 32(3):237-244. PubMed ID: 29688078
[TBL] [Abstract][Full Text] [Related]
15. Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study.
Dinapoli L; Maschio M; Jandolo B; Fabi A; Pace A; Sperati F; Muti P
Neurol Sci; 2009 Aug; 30(4):353-9. PubMed ID: 19415165
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of randomized trials on first line and adjunctive levetiracetam.
Lo BW; Kyu HH; Jichici D; Upton AM; Akl EA; Meade MO
Can J Neurol Sci; 2011 May; 38(3):475-86. PubMed ID: 21515509
[TBL] [Abstract][Full Text] [Related]
17. Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review.
Weijenberg A; Brouwer OF; Callenbach PM
CNS Drugs; 2015 May; 29(5):371-82. PubMed ID: 26013703
[TBL] [Abstract][Full Text] [Related]
18. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
Lim DA; Tarapore P; Chang E; Burt M; Chakalian L; Barbaro N; Chang S; Lamborn KR; McDermott MW
J Neurooncol; 2009 Jul; 93(3):349-54. PubMed ID: 19169651
[TBL] [Abstract][Full Text] [Related]
19. A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures.
Usery JB; Michael LM; Sills AK; Finch CK
J Neurooncol; 2010 Sep; 99(2):251-60. PubMed ID: 20146087
[TBL] [Abstract][Full Text] [Related]
20. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
